MedTrace Logo

Medina Embolization Device In Neurovascular Aneurysm Study

NCT02982200 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2019-05-17

No results posted yet for this study

Summary

A global prospective, multi-center, single-arm, post-market clinical follow-up (PMCF) study conducted to assess the performance of the Medina Embolization Device when used in unruptured and ruptured intracranial aneurysms.

Conditions

  • Intracranial Aneurysm

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    collaborator INDUSTRY

  • Medtronic Neurovascular Clinical Affairs

    lead INDUSTRY

Principal Investigators

  • Patrick Brouwer, Dr · Karolinska University Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-15
Primary Completion
2018-10-22
Completion
2018-10-22

Countries

  • Austria
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982200 on ClinicalTrials.gov